Compressive compared with tensile loading of medial collateral ligament scar in vitro uniquely influences mRNA levels for aggrecan, collagen type II, and collagenase.
To test the hypothesis that loading conditions can be used to engineer early ligament scar behaviors, we used an in vitro system to examine the effect that cyclic hydrostatic compression and cyclic tension applied to 6-week rabbit medial collateral ligament scars had on mRNA levels for matrix molecules, collagenase, and the proto-oncogenes c-fos and c-jun. Our specific hypothesis was that tensile stress would promote more normal mRNA expression in ligament whereas compression would lead to higher levels of mRNA for cartilage-like molecules. Femur (injured medial collateral ligament)-tibia complexes were subjected to a hydrostatic pressure of 1 MPa or a tensile stress of 1 MPa of 0.5 Hz for 1 minute followed by 14 minutes of rest. On the basis of a preliminary optimization experiment, this 15-minute testing cycle was repeated for 4 hours. Semiquantitative reverse transcription-polymerase chain reaction analysis was performed for mechanically treated medial collateral ligament scars with use of rabbit specific primer sets for types I, II, and III collagen, decorin, biglycan, fibromodulin, versican, aggrecan, collagenase, c-fos, c-jun, and a housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase. Cyclic hydrostatic compression resulted in a statistically significant increase in mRNA levels of type-II collagen (171% of nonloaded values) and aggrecan (313% of nonloaded values) but statistically significant decreases in collagenase mRNA levels (35% of nonloaded values). Cyclic tension also resulted in a statistically significant decrease in collagenase mRNA levels (66% of nonloaded values) and an increase in aggrecan mRNA levels (458% of nonloaded values) but no significant change in the mRNA levels for the other molecules. The results show that it is possible to alter mRNA levels for a subset of genes in scar tissue by supplying unique mechanical stimuli in vitro and thus that further investigation of scar engineering for potential reimplantation appears feasible.
Majima
T
T
McCaig Center for Joint Injury and Arthritis Research, University of Calgary, Alberta, Canada.
Marchuk
L L
LL
Sciore
P
P
Shrive
N G
NG
Frank
C B
CB
Hart
D A
DA
D053674:Aggrecans; D000818:Animals; D002921:Cicatrix / Q000201:enzymology / Q000503:physiopathology; D003094:Collagen / Q000235:genetics*; D017364:Collagenases / Q000235:genetics*; D019245:Compressive Strength / Q000502:physiology; D017931:DNA Primers; D005109:Extracellular Matrix / Q000201:enzymology; D016326:Extracellular Matrix Proteins; D005260:Female; D015870:Gene Expression / Q000502:physiology; D066298:In Vitro Techniques; D037181:Lectins, C-Type; D017888:Medial Collateral Ligament, Knee / Q000201:enzymology / Q000293:injuries* / Q000503:physiopathology*; D011509:Proteoglycans / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis; D011817:Rabbits; D013718:Tensile Strength / Q000502:physiology; D016474:Weight-Bearing / Q000502:physiology
D053674:Aggrecans; D017931:DNA Primers; D016326:Extracellular Matrix Proteins; D037181:Lectins, C-Type; D011509:Proteoglycans; D012333:RNA, Messenger; D003094:Collagen; D017364:Collagenases